** = Publikationen gelistet in SCI/SSCI/Pubmed
** Anthofer, M; Windisch, M; Haller, R; Ehmann, S; Wrighton, S; Miller, M; Schernthanner, L; Kufferath, I; Schauer, S; Jelušić, B; Kienesberger, S; Zechner, EL; Posselt, G; Vales-Gomez, M; Reyburn, HT; Gorkiewicz, G
Immune evasion by proteolytic shedding of natural killer group 2, member D ligands in Helicobacter pylori infection.
Front Immunol. 2024; 15: 1282680
Doi: 10.3389/fimmu.2024.1282680
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Horvath, A; Haller, R; Feldbacher, N; Habisch, H; Žukauskaitė, K; Madl, T; Stadlbauer, V
Probiotic Therapy of Gastrointestinal Symptoms During COVID-19 Infection: A Randomized, Double-Blind, Placebo-Controlled, Remote Study.
Nutrients. 2024; 16(22):
Doi: 10.3390/nu16223970
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Haller, R; Hazia, O; Traub, J; Horvath, A; Stadlbauer, V
Nitrogen recycling by the gut microbiome in sarcopenia
J HEPATOL. Abstracts. 2024; 80: S284-S284.-EASL Congress; JUN 5-8, 2024; Milan, ITALY.
[Poster]
Web of Science
** Haller, R; Fürst, S; Woltsche, J; Gulden, L; Schwarzl, J; Traub, J; Feldbacher, N; Aliwa, B; Madl, T; Fauler, G; Horvath, A; Stadlbauer, V
Phascolarctobacterium as a predictor for survival in cirrhotic patients
J HEPATOL. 2023; 78: S354-S354.
[Poster]
Web of Science
** Haller, R; Aliwa, B; Horvath, A; Stadlbauer, V
Intestinal hyperpermeability in cirrhosis is predictive for survival and associated with distinct microbiome changes
J HEPATOL. Abstracts of The International Liver Congress 2022. 2022; 77: S179-S179.-International Liver Congress; JUN 22-26, 2022; London, ENGLAND.
[Poster]
Web of Science